Emerald Clinical’s team will be attending Bio Japan 2025, October 8-10 in Yokohama.
Book a Meeting
Excellence in Early Phase Clinical Research
We are proud to have been selected to exhibit as part of Team Australia’s exhibition at BioJapan 2025. Come and visit us at the Australian pavilion booth and meet our Global Partner and Early Phase experts.
Beyond Partners: Collaborators in your global clinical development programs. Bio Japan is Asia’s premier bio-industry partnering event. It’s a perfect opportunity to meet with the team from Emerald Clinical Trials and learn how we can become your CRO partner of choice to accelerate your clinical development program.
Global Site Global Regulatory and Operational Experience
Local Relationships and Insights
Emerald Clinical’s 20+ year APAC heritage is coupled with our regulatory and operational expertise in early 70 geographic locations and a strong KOL network to streamline your clinical trial management and give your drug development global reach and impact.
Emerald Clinical offers a significant advantage for faster, smoother, and more reliable trials. We have more than two decades of global experience and long-term relationships with KOLs, sites, teams, and vendors. We’ve partnered with more than 100 biotech companies and understand the need for tailored solutions and positioning for clinical relevance and regulatory approval.
Why Emerald Clinical?
With decades of on-the-ground, cross-functional experience in all study aspects, Emerald Clinical’s therapeutically aligned teams can handle the most complex trials with precision. Accelerate your progress with our expertise in:
- Navigating rapidly shifting global regulatory environments
- Incorporating valuable regional/local knowledge for more effective recruitment and retention
- Streamlined trial management for faster startup, on-time recruitment, and high retention rates
- Therapeutic excellence in Renal, Oncology, and Cardiometabolic
- Dedicated Early Phase teams and assistance with Australian R&D tax benefits
- Access to qualified sites and patients in 70 countries
- Creating early strategies that lead to faster regulatory approval and commercialization
Engage Locally: Align Globally.
Meet our Team
Learn more about our Early Phase capabilities
Tamara Murdock
Yoshihiro (Yoshi) Takizawa
